Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 973912, 11 pages
http://dx.doi.org/10.1155/2015/973912
Research Article

Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells

1Istituto di Ricerca Pediatrica Città della Speranza (IRP), Corso Stati Uniti 4, 35127 Padova, Italy
2Department of Woman and Child Health, University of Padova, Via Giustiniani 3, 35128 Padova, Italy
3Department of Neuroscience, University of Padova, Via Giustiniani 2, 35128 Padova, Italy

Received 28 May 2015; Accepted 26 July 2015

Academic Editor: Mariaelena Pierobon

Copyright © 2015 Chiara Frasson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. N. Louis, H. Ohgaki, O. D. Wiestler et al., “The 2007 WHO classification of tumours of the central nervous system,” Acta Neuropathologica, vol. 114, no. 2, pp. 97–109, 2007. View at Publisher · View at Google Scholar
  2. M. R. Grimmer and W. A. Weiss, “Childhood tumors of the nervous system as disorders of normal development,” Current Opinion in Pediatrics, vol. 18, no. 6, pp. 634–638, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. P. J. Scotting, D. A. Walker, and G. Perilongo, “Childhood solid tumours: a developmental disorder,” Nature Reviews Cancer, vol. 5, no. 6, pp. 481–488, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. Thompson, C. Fuller, T. L. Hogg et al., “Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations,” Journal of Clinical Oncology, vol. 24, no. 12, pp. 1924–1931, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Yokota, S. Nishizawa, S. Ohta et al., “Role of Wnt pathway in medulloblastoma oncogenesis,” International Journal of Cancer, vol. 101, no. 2, pp. 198–201, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. R. H. Zurawel, S. A. Chiappa, C. Allen, and C. Raffel, “Sporadic medulloblastomas contain oncogenic beta-catenin mutations,” Cancer Research, vol. 58, no. 5, pp. 896–899, 1998. View at Google Scholar · View at Scopus
  7. M. Kool, A. Korshunov, M. Remke et al., “Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas,” Acta Neuropathologica, vol. 123, no. 4, pp. 473–484, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. P. A. Northcott, D. J. Shih, J. Peacock et al., “Subgroup-specific structural variation across 1,000 medulloblastoma genomes,” Nature, vol. 488, no. 7409, pp. 49–56, 2012. View at Google Scholar
  9. N. Baryawno, B. Sveinbjörnsson, S. Eksborg, C. S. Chen, P. Kogner, and J. I. Johnsen, “Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth,” Cancer Research, vol. 70, no. 1, pp. 266–276, 2010. View at Publisher · View at Google Scholar
  10. A. S. Guerreiro, S. Fattet, B. Fischer et al., “Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration,” Clinical Cancer Research, vol. 14, no. 21, pp. 6761–6769, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Hartmann, B. Digon-Söntgerath, A. Koch et al., “Phosphatidylinositol 3′-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN,” Clinical Cancer Research, vol. 12, no. 10, pp. 3019–3027, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Fan and C. G. Eberhart, “Medulloblastoma stem cells,” Journal of Clinical Oncology, vol. 26, no. 17, pp. 2821–2827, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Liu, N. Chi, J. Zhang, W. Zhu, Y. Bian, and H. Chen, “Isolation and characterization of cancer stem cells from medulloblastoma,” Genetics and Molecular Research, vol. 14, no. 2, pp. 3355–3361, 2015. View at Publisher · View at Google Scholar
  14. F. Pistollato, E. Rampazzo, L. Persano et al., “Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate,” Stem Cells, vol. 28, no. 11, pp. 1918–1929, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. K. Singh, C. Hawkins, I. D. Clarke et al., “Identification of human brain tumour initiating cells,” Nature, vol. 432, no. 7015, pp. 396–401, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Dubrovska, S. Kim, R. J. Salamone et al., “The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 1, pp. 268–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Zhou, J. Wulfkuhle, H. Zhang et al., “Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 41, pp. 16158–16163, 2007. View at Publisher · View at Google Scholar
  18. V. N. Kolev, Q. G. Wright, C. M. Vidal et al., “PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells,” Cancer Research, vol. 75, no. 2, pp. 446–455, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Pistollato, L. Persano, A. Della Puppa, E. Rampazzo, and G. Basso, “Isolation and expansion of regionally defined human glioblastoma cells in vitro,” in Current Protocols in Stem Cell Biology, chapter 3, unit 3.4, 2011. View at Google Scholar
  20. E. Rampazzo, L. Persano, F. Pistollato et al., “Wnt activation promotes neuronal differentiation of glioblastoma,” Cell Death & Disease, vol. 4, article e500, 2013. View at Publisher · View at Google Scholar
  21. B. Accordi, V. Espina, M. Giordan et al., “Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALL,” PLoS ONE, vol. 5, no. 10, Article ID e13552, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Pistollato, E. Rampazzo, S. Abbadi et al., “Molecular mechanisms of HIF-1α modulation induced by oxygen tension and BMP2 in glioblastoma derived cells,” PLoS ONE, vol. 4, no. 7, Article ID e6206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Shaw, P. Cohen, and D. R. Alessi, “The activation of protein kinase B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2,” Biochemical Journal, vol. 336, part 1, pp. 241–246, 1998. View at Google Scholar · View at Scopus
  24. G. Otaegi, M. J. Yusta-Boyo, E. Vergaño-Vera et al., “Modulation of the PI 3-kinase-Akt signalling pathway by IGF-I and PTEN regulates the differentiation of neural stem/precursor cells,” Journal of Cell Science, vol. 119, part 13, pp. 2739–2748, 2006. View at Google Scholar
  25. J. J. Gibbons, R. T. Abraham, and K. Yu, “Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth,” Seminars in Oncology, vol. 36, supplement 3, pp. S3–S17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Bertacchini, M. Guida, B. Accordi et al., “Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis,” Leukemia, vol. 28, no. 11, pp. 2197–2205, 2014. View at Publisher · View at Google Scholar
  27. S. J. Gardai, D. A. Hildeman, S. K. Frankel et al., “Phosphorylation of Bax ser184 by Akt regulates its activity and apoptosis in neutrophils,” The Journal of Biological Chemistry, vol. 279, no. 20, pp. 21085–21095, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. D. D'Amours, F. R. Sallmann, V. M. Dixit, and G. G. Poirier, “Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: Implications for apoptosis,” Journal of Cell Science, vol. 114, no. 20, pp. 3771–3778, 2001. View at Google Scholar · View at Scopus
  29. G. J. Pilkington, “Cancer stem cells in the mammalian central nervous system,” Cell Proliferation, vol. 38, no. 6, pp. 423–433, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. J. Ward, L. Lee, K. Graham et al., “Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma,” Cancer Research, vol. 69, no. 11, pp. 4682–4690, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J. L. Lasky III, M. Choe, and I. Nakano, “Cancer stem cells in pediatric brain tumors,” Current Stem Cell Research and Therapy, vol. 4, no. 4, pp. 298–305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Dimitrova and A. Arcaro, “Targeting the PI3K/AKT/mTOR signaling pathway in medulloblastoma,” Current Molecular Medicine, vol. 15, no. 1, pp. 82–93, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. N. U. Gerber, M. Mynarek, K. von Hoff, C. Friedrich, A. Resch, and S. Rutkowski, “Recent developments and current concepts in medulloblastoma,” Cancer Treatment Reviews, vol. 40, no. 3, pp. 356–365, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. R. J. Gilbertson, “Medulloblastoma: signalling a change in treatment,” The Lancet Oncology, vol. 5, no. 4, pp. 209–218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. A. V. Kulkarni, J. Piscion, I. Shams, and E. Bouffet, “Long-term quality of life in children treated for posterior fossa brain tumors,” Journal of Neurosurgery: Pediatrics, vol. 12, no. 3, pp. 235–240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. A. M. Kenney, H. R. Widlund, and D. H. Rowitch, “Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors,” Development, vol. 131, no. 1, pp. 217–228, 2004. View at Google Scholar
  37. P. Niewiadomski, A. Zhujiang, M. Youssef, and J. A. Waschek, “Interaction of PACAP with Sonic hedgehog reveals complex regulation of the hedgehog pathway by PKA,” Cellular Signalling, vol. 25, no. 11, pp. 2222–2230, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Romer and T. Curran, “Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics,” Cancer Research, vol. 65, no. 12, pp. 4975–4978, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Manoranjan, C. Venugopal, N. McFarlane et al., “Medulloblastoma stem cells: where development and cancer cross pathways,” Pediatric Research, vol. 71, no. 4, pp. 516–522, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. C. M. Hooper, S. M. Hawes, U. R. Kees, N. G. Gottardo, and P. B. Dallas, “Gene expression analyses of the spatio-temporal relationships of human medulloblastoma subgroups during early human neurogenesis,” PLoS ONE, vol. 9, no. 11, Article ID e112909, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Lee, J. D. Kessler, T.-A. Read et al., “Isolation of neural stem cells from the postnatal cerebellum,” Nature Neuroscience, vol. 8, no. 6, pp. 723–729, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. A. J. Fink, C. Englund, R. A. M. Daza et al., “Development of the deep cerebellar nuclei: transcription factors and cell migration from the rhombic lip,” The Journal of Neuroscience, vol. 26, no. 11, pp. 3066–3076, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Y. Wang, M. F. Rose, and H. Y. Zoghbi, “Math1 expression redefines the rhombic lip derivatives and reveals novel lineages within the brainstem and cerebellum,” Neuron, vol. 48, no. 1, pp. 31–43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Grammel, M. Warmuth-Metz, A. O. von Bueren et al., “Sonic hedgehog-associated medullobla stoma arising from the cochlear nuclei of the brainstem,” Acta Neuropathologica, vol. 123, no. 4, pp. 601–614, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Salsano, B. Pollo, M. Eoli, M. T. Giordana, and G. Finocchiaro, “Expression of MATH1, a marker of cerebellar granule cell progenitors, identifies different medulloblastoma sub-types,” Neuroscience Letters, vol. 370, no. 2-3, pp. 180–185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Hambardzumyan, O. J. Becher, M. K. Rosenblum, P. P. Pandolfi, K. Manova-Todorova, and E. C. Holland, “PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo,” Genes and Development, vol. 22, no. 4, pp. 436–448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. C. A. Easley, A. Ben-Yehudah, C. J. Redinger et al., “mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells,” Cellular Reprogramming, vol. 12, no. 3, pp. 263–273, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Ehrhardt, R. B. Craveiro, M. I. Holst, T. Pietsch, and D. Dilloo, “The PI3K inhibitor GDC-0941 displays promising in vitro and in vivo efficacy for targeted medulloblastoma therapy,” Oncotarget, vol. 6, no. 2, pp. 802–813, 2015. View at Google Scholar · View at Scopus
  49. C. W. Ong, L. G. Kim, H. H. Kong et al., “CD133 expression predicts for non-response to chemotherapy in colorectal cancer,” Modern Pathology, vol. 23, no. 3, pp. 450–457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Persano, F. Pistollato, E. Rampazzo et al., “BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1alpha stability and MGMT expression,” Cell Death and Disease, vol. 3, no. 10, article e412, 2012. View at Publisher · View at Google Scholar · View at Scopus